V8L (p.Val8Leu) variant of ACTN2 (Alpha-actinin-2)

V8L (p.Val8Leu) in ACTN2 (Alpha-actinin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data and structural context.

V8L (p.Val8Leu) variant details